Skip to main content
Intermediate Technical IVT

bladder preservation therapy

Multimodal treatment approach combining chemotherapy and radiation to treat muscle-invasive bladder cancer while preserving the bladder.

Full Definition

Bladder preservation therapy, also known as trimodality therapy, is an organ-sparing treatment approach for muscle-invasive bladder cancer that combines transurethral resection, concurrent chemoradiation therapy, and close surveillance. This approach offers an alternative to radical cystectomy for carefully selected patients with muscle-invasive disease. The treatment protocol typically involves initial transurethral resection followed by concurrent chemotherapy (often cisplatin-based) and external beam radiation therapy, with cystoscopic monitoring to assess response.

Usage

Usage note: Use 'preservation' not 'preserving' in formal contexts.

In Context

  • "The patient opted for bladder preservation therapy rather than radical cystectomy." — Treatment planning note
  • "Bladder preservation therapy achieved complete response in 70% of patients at 6 months." — Clinical trial report

Also known as

trimodality therapy organ-sparing therapy bladder-sparing treatment

Contrasted with

radical cystectomy cystectomy

Don't confuse with

neoadjuvant therapy adjuvant therapy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON